News

Learn more about our company, latest developments in clinical diagnostics, and scientific breaktroughs in the rare disease field.

Stay on top, subscribe to our newsletter and follow us on social media.

  1. News

News


CENTOGENE has recently added numerous single gene tests and next generation sequencing (NGS) panels to its portfolio....


Dr. Arndt Rolfs, CEO CENTOGENE, presented at JP Morgan Healthcare Conference 2017 about CENTOGENE's self-amplifying...


For the first time, ever, the Parkinson’s Institute and Clinical Center and CENTOGENE have entered into a collaboration...


Arndt Rolfs, CEO and founder of CENTOGENE, will present the company’s business model on Wednesday, January 11, 2017, at...


CENTOGENE announces today a new sequencing facility for rare hereditary disorders, which will use Illumina’s HiSeq X®...


The “Deutschlandstipendium” is a scholarship that helps support gifted and talented students enrolled at German...


CENTOGENE is proud to contribute to the Face2Gene 60 Day Challenge. This initiative by FDNA was started November 1,...


CENTOGENE successfully became part of the Illumina Propel Certification Program for Core and Service Labs.


CENTOEGENE AG (CENTOGENE) and Interactive Biosoftware (IBS) announce to start their collaboration on the integration of...


Collaboration between FDNA, the developer of the Face2Gene Suite and CENTOGENE, worldwide leader in genetic diagnostics,...